Skip to main content
Journal of Clinical Laboratory Analysis logoLink to Journal of Clinical Laboratory Analysis
. 2009 Mar 13;23(2):132–138. doi: 10.1002/jcla.20303

Serum prolidase activity and oxidative status in patients with bronchial asthma

Alpay Cakmak 1,, Dost Zeyrek 1, Ali Atas 1, Hakim Celik 2, Nurten Aksoy 2, Ozcan Erel 2
PMCID: PMC6649124  PMID: 19288447

Abstract

Asthma is a disease where there is an accumulation of collagen in the reticular basal membrane of the airway leading to chronic inflammation. The enzyme prolidase plays an important role in the breakdown of collagen and the breakdown of intracellular protein especially in the final stage when peptides and dipeptides contain a high level of proline. To evaluate the relationship between prolidase activity and oxidative status in asthma patients. Comparison was made between 42 patients diagnosed with bronchial asthma and 32 healthy children of similar age and gender. Serum prolidase activity was measured spectrophotometrically. Oxidative status was determined using total antioxidant capacity (TAC) and total oxidant status (TOS) measurement. The prolidase activity of the asthma patient group was statistically significant compared with the control group (P≤0.001). TAC and TOS levels in the asthma patient group were higher than the control group (P≤0.001, P≤0.002, respectively). No correlation was found between the prolidase and oxidative levels of the two groups. A positive correlation was determined between the prolidase activity and TAC in the asthma patient group (P≤0.001, r=0.501). The prolidase enzyme activity, which plays a role in the collagen turnover, was low in the asthma patients; therefore, their collagen metabolism had undergone a change and this indicates that there may be an effect on the accumulation of collagen in the reticular basal membrane. Moreover, the high level of TOS indicates that these patients were exposed to severe oxidative stress with an increased TAC response. J. Clin. Lab. Anal. 23:132–138, 2009. © 2009 Wiley‐Liss, Inc.

Keywords: asthma, prolidase activity, airway remodeling, oxidative status

REFERENCES

  • 1. Cokugras H, Akcakaya N, Seckin I, et al. Ultrastructural examination of bronchial biopsy specimens from children with moderate asthma. Thorax 2001;56:25–29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Pohunek P, Roche WR, Tarzikova J, et al. Eosinophilic inflammation in the bronchial mucosa in children with bronchial asthma [abstract]. Eur Respir J 2000;11:160s. [Google Scholar]
  • 3. Frieri M. Asthma concepts in new millennium‐update in asthma pathophysiology. Allergy Asthma Proc 2005;26:83–88. [PubMed] [Google Scholar]
  • 4. Flood‐Page P, Menzies‐Gow S, Phipps S, et al. Reduction of tissue eosinophils in mild atopic asthmatics by an ant‐IL‐5 monoclonal antibody (mepolizumab) is associated with inhibition of tenascin deposition within the bronchial epithelial basement membrane. Am J Respir Crit Care Med 2002;165:B42. [Google Scholar]
  • 5. Brewster CE, Howarth PH, Djukanovic R, et al. Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 1990;3:507–511. [DOI] [PubMed] [Google Scholar]
  • 6. Frieri M. Advances in understanding allergic asthma. Allergy Asthma Proc 2007;28:614–619. [DOI] [PubMed] [Google Scholar]
  • 7. Hashimoto N, Jin H, Liu T, et al. Bone marrow‐derived progenitor cells in pulmonary fibrosis. J Clin Invest 2004;113:243–252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Lenz AG, Hinze‐Heyn H, Schneider A, et al. Influence of inflammatory mechanisms on the redox balance in interstitial lung diseases. Respir Med 2004;98:737–745. [DOI] [PubMed] [Google Scholar]
  • 9. Ernst P. Review article: The role of inflammation in the pathogenesis of gastric cancer. Aliment Pharmacol Ther 1999;13:13–18. [DOI] [PubMed] [Google Scholar]
  • 10. Palka JA, Phang JM. Prolidase activity in fibroblasts is regulated by interaction of extracellular matrix with cell surface integrin receptors. J Cell Biochem 1997;67:166–175. [DOI] [PubMed] [Google Scholar]
  • 11. Abraham P, Wilfred G, Ramakrishna B. Plasma prolidase may be an index of liver fibrosis in the rat. Clin Chim Acta 1997;295:199–202. [DOI] [PubMed] [Google Scholar]
  • 12. Kavala M, Zindanci I, Sudogan S, et al. Ulcus cruris associated with prolidase deficiency. Dermatol Online J 2006;12:24. [PubMed] [Google Scholar]
  • 13. Zanaboni G, Dyne KM, Rossi A, et al. Prolidase deficiency. Biochemical study of erythrocyte and skin fibroblast prolidase activity in Italian patients. Haematologica 1994;79:13–18. [PubMed] [Google Scholar]
  • 14. Myara I, Myara A, Mangeot M, et al. Plasma prolidase activity: A possible index of collagen catabolism in chronic liver disease. Clin Chem 1984;30:211–215. [PubMed] [Google Scholar]
  • 15. Vignola AM, Chanez P, Campbell AM, et al. Airway inflammation in mild intermittent and in persistent asthma. Am J Respir Crit Care Med 1998;157:403–409. [DOI] [PubMed] [Google Scholar]
  • 16. Grisham M B, Jourd'heuil D, Wink DA. Review article: Chronic inflammation and reactive oxygen and nitrogen metabolism—Implications in DNA damage and mutagenesis. Aliment Pharmacol Ther 2000;14:3–9. [DOI] [PubMed] [Google Scholar]
  • 17. Loo RM, Kumar K, Frieri M. Emergency department evaluation, treatment, hospital admission and sIgE levels in African American and Hispanic pediatric asthmatics. Clin Immunol 2007:123:S76. [Google Scholar]
  • 18. Andreadis AA, Hazen SL, Comhair SA, et al. Oxidative and nitrosative events in asthma. Free Radic Biol Med 2003;35:213–215. [DOI] [PubMed] [Google Scholar]
  • 19. Owen S, Pearson D, Suarez‐Mendez V, et al. Evidence of free‐radical activity in asthma. N Engl J Med 1991;325:586–587. [DOI] [PubMed] [Google Scholar]
  • 20. Pryor WA, Church DF. Aldehydes, hydrogen peroxide, and organic radicals as mediators of ozone toxicity. Free Radic Biol Med 1991;11:41–46. [DOI] [PubMed] [Google Scholar]
  • 21. Sarban S, Kocyigit A, Yazar M, et al. Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis. Clin Biochem 2005;38:981–986. [DOI] [PubMed] [Google Scholar]
  • 22. Frieri M. Bronchopulmonary dysplasia in premature infants. Allergy Clin Immunol Int—J World Allergy Organ 2006;18. [Google Scholar]
  • 23. Sirven V, Beck G, Chrostowski D, et al. Monitoring circulating nitric oxide levels in infants with bronchopulmonary dysplasia for disease activity. Curr Pediatr Rev 2005;1:l91–195. [Google Scholar]
  • 24. Beck‐Speier I, Dayal N, Karg E, et al. Oxidative stress and lipid mediators induced in alveolar macrophages by ultrafine particles. Free Radic Biol Med 2005;38:1080–1092. [DOI] [PubMed] [Google Scholar]
  • 25. Mac Nee W. Oxidative stress and lung inflammation in airways disease. Eur J Pharmacol 2001;429:195–207. [DOI] [PubMed] [Google Scholar]
  • 26. Global Initiative for Asthma . Global Strategy for Asthma Management and Prevention, revised edition. Bethesda, MD: National Institutes of Health, National Heart, Lung and Blood Institute, 2002. [Google Scholar]
  • 27. http://www.cdc.gov/nchs/about/major/nhanes/growthcharts/datafiles.htm.
  • 28. Dreborg S, Frew A. Allergen standardization and skin tests. EAACI position paper. Allergy 1993;48:49–82. [PubMed] [Google Scholar]
  • 29. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004;37:112–119. [DOI] [PubMed] [Google Scholar]
  • 30. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005;38:1103–1111. [DOI] [PubMed] [Google Scholar]
  • 31. Nourooz Zadeh J. Ferrous ion oxidation in presence of xylenol orange for detection of lipid hydroperoxides in plasma. Methods Enzymol 1999;300:58–62. [DOI] [PubMed] [Google Scholar]
  • 32. Myara I, Myara A, Mangeot M, et al. Plasma prolidase activity: A possible index of collagen catabolism in chronic liver disease. Clin Chem 1984;30:211–215. [PubMed] [Google Scholar]
  • 33. Myara I, Charpentier C, Lemonnier A. Optimal conditions for prolidase assay by proline colorimetric determination: Application to iminodipeptiduria. Clin Chim Acta 1982;125:193–205. [DOI] [PubMed] [Google Scholar]
  • 34. Chinard FP. Photometric estimation of proline and ornithine. J Biol Chem 1952;199:91–95. [PubMed] [Google Scholar]
  • 35. Braman SS. The global burden of asthma. Chest 2006;130:4S–12S. [DOI] [PubMed] [Google Scholar]
  • 36. Bousquet J, Jeffery PK, Busse WW, et al. Asthma: From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000;161:1720–1745. [DOI] [PubMed] [Google Scholar]
  • 37. Hui KS, Lajtha A. Prolidase activity in brain: Comparison with other organs. J Neurochem 1978;30:321–327. [DOI] [PubMed] [Google Scholar]
  • 38. Myara I, Myara A, Mangeat M, et al. Plasma prolidase activity: A possible index of collagen catabolism in chronic liver disease. Clin Chem 1984;30:211–215. [PubMed] [Google Scholar]
  • 39. Oner P, Gurdol F, Oner‐Iyidon Y, et al. Evaluation of the effect of low‐dose oral theophylline therapy on some bone turnover markers and serum prolidase I activity in mild asthmatics. Pharmacol Res 1999;40:189–193. [DOI] [PubMed] [Google Scholar]
  • 40. Suleyman K, Ahmet A, Mehmet A, et al. The effects of different treatments on prolidase and antioxidant enzyme activities in patients with bronchial asthma. Environ Toxicol Pharmacol 2006;22:35–39. [DOI] [PubMed] [Google Scholar]
  • 41. Sansone G, Matin A, Wang SF, et al. Theophylline inhibits the production of nitric oxide by peripheral blood in mononuclear cells from patients with asthma. Ann Allergy Asthma Immunol l998;81:90–95. [DOI] [PubMed] [Google Scholar]
  • 42. Mak JCW, Leung HCM, Ho SP, et al. Systemic oxidative and antioxidative status in Chinese patients with asthma. J Allergy Clin Immunol 2004;114:260–264. [DOI] [PubMed] [Google Scholar]
  • 43. Liao MF, Chen CC, Hsu MH. Evaluation of the serum antioxidant status in asthmatic children. Acta Paediatr Taiwan 2004;45:213–217. [PubMed] [Google Scholar]
  • 44. Nadeem A, Chhabra SK, Masood A, et al. Increased oxidative stress and altered levels of antioxidants in asthma. J Allergy Clin Immunol 2003;111:72–78. [DOI] [PubMed] [Google Scholar]
  • 45. Zimmermann J, Silverman R, Frieri M. Specific IgE levels in moderate to severe asthmatics in the emergency department. Ann Allergy Asthma Immunol 2006;96:151. [Google Scholar]
  • 46. Karabulut AB, Atambay M, Karaman U, et al. House dust‐mites: Effect on antioxidant enzyme activities. Med Sci Monit 2006;12:CR378–CR381. [PubMed] [Google Scholar]

Articles from Journal of Clinical Laboratory Analysis are provided here courtesy of Wiley

RESOURCES